Tarsus Pharmaceuticals, Inc.
TARSNASDAQHealthcare● Active
$60.82
+$1.18(+1.98%)
Market Cap$2.6B
P/E Ratio—
52W High$85.25
52W Low$38.51
Tarsus Pharmaceuticals, Inc.（TARS）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · TARS · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.07B) | ($0.12B) | ($0.14B) | ($0.06B) | ($0.01B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.04B | $0.03B | $0.02B | $0.01B | $0.01B |
| Change in Working Capital | $0.01B | $0.00B | $0.00B | ($0.00B) | $0.00B |
| Net Cash from Operations | ($0.01B) | ($0.08B) | ($0.12B) | ($0.05B) | $0.00B |
| Investing Activities | |||||
| Capital Expenditure | ($0.01B) | ($0.00B) | ($0.01B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | ($0.39B) | ($0.27B) | ($0.03B) | ($0.15B) | $0.00B |
| Sales of Investments | $0.36B | $0.07B | $0.17B | $0.01B | $0.00B |
| Net Cash from Investing | ($0.04B) | ($0.20B) | $0.14B | ($0.14B) | ($0.00B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.04B | $0.01B | $0.02B | $0.00B |
| Net Cash from Financing | $0.14B | $0.15B | $0.13B | $0.09B | $0.00B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.02B) | ($0.08B) | ($0.12B) | ($0.05B) | $0.00B |
| FCF Margin %(computed) | -4.94% | -46.24% | -704.96% | -191.88% | 5.54% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Tarsus Pharmaceuticals, Inc.
关于Tarsus Pharmaceuticals, Inc.（TARS）现金流量表
Tarsus Pharmaceuticals, Inc. 2025财年经营活动现金流($0.01B)，自由现金流($0.02B)（FCF利润率-4.94%），资本支出($0.01B)。
常见问题
TARS · 4 问Tarsus Pharmaceuticals, Inc. 2025财年自由现金流($0.02B)，同比up73.6%。
TARS free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10